NCT05445908 2025-11-17
SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 2 Active not recruiting
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.